We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Induction Healthcare Group Plc | LSE:INHC | London | Ordinary Share | GB00BJ0M3545 | ORD 0.5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 9.50 | 434 | 08:00:29 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 9.00 | 10.00 | 9.675 | 9.375 | 9.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Business Services, Nec | 14.36M | -3.26M | -0.0353 | -2.69 | 8.78M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:15:24 | O | 64 | 10.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 16/5/2025 | 12:03 | UK RNS | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
| 14/5/2025 | 11:25 | UK RNS | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
| 13/5/2025 | 11:43 | UK RNS | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
| 12/5/2025 | 14:07 | ALNC |  *Induction Healthcare shareholders approve takeover by VitalHub |
| 12/5/2025 | 14:00 | UK RNS | Induction Healthcare Group PLC Results of Court Meeting and General Meeting |
| 07/5/2025 | 11:09 | UK RNS | Stonehage Fleming Investment Mgt Ld Form 8.3 - Induction Healthcare Group.. |
| 07/5/2025 | 10:57 | UK RNS | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
| 06/5/2025 | 11:15 | UK RNS | Induction Healthcare Group PLC Form 8.3 - Induction Healthcare Group PLC |
| 06/5/2025 | 11:13 | UK RNS | Induction Healthcare Group PLC Form 8.3 - Induction Healthcare Group PLC |
| 02/5/2025 | 12:08 | UK RNS | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) - Induction Healthcare.. |
Induction Healthcare (INHC) Share Charts1 Year Induction Healthcare Chart |
|
1 Month Induction Healthcare Chart |
Intraday Induction Healthcare Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 08/1/2025 | 13:41 | Induction Healthcare | 66 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 13:15:24 | 10.00 | 64 | 6.40 | O |
| 13:15:24 | 9.00 | 360 | 32.40 | O |
| 13:15:24 | 9.00 | 10 | 0.90 | O |
| Top Posts |
|---|
Posted at 22/5/2025 09:20 by Induction Healthcare Daily Update Induction Healthcare Group Plc is listed in the Business Services, Nec sector of the London Stock Exchange with ticker INHC. The last closing price for Induction Healthcare was 9.50p.Induction Healthcare currently has 92,380,300 shares in issue. The market capitalisation of Induction Healthcare is £8,776,129. Induction Healthcare has a price to earnings ratio (PE ratio) of -2.69. This morning INHC shares opened at 9.50p |
Posted at 01/5/2024 11:59 by citys2874 NHS ENGLAND Contract news should catapult this share due very soon |
Posted at 29/4/2024 09:46 by citys2874 Induction Healthcare Group PLCFull Year Trading Update London, UK - 29 April 2024: Induction Healthcare Group PLC ("Induction", the "Company", or the "Group"; AIM: INHC), a leading digital health platform driving transformation of healthcare systems, today announces the following trading update for the year ending 31 March 2024. Financial Highlights (unaudited) · Revenues of approximately £14.1m (FY23: £13.6m), broken down as follows: o Attend Anywhere: £8.5m o Zesty: £4.9m o Guidance: £0.7m · Adjusted EBITDA* expected to be in line with market expectation at approximately £0.3m (FY23: -£3.6m) · Gross margin improvement to 77.9% (FY23: 63.1%) · Net cash £3.7m (31 March 2023: £4.3m) * Adjusted EBITDA is Operating result from continuing operations before depreciation (£0.1m), amortisation (£4.3m) and net of non-cash/ non-operating items (£0.2m) Operational Highlights · New NHS patient portal contracts compensate for downward pressure on video pricing. · Completed effective cost containment and margin enhancement programme. · Achieved objective of self-sustaining growth and cash flow breakeven. · Signed a total of £3.4m (includes previously-announced contracts) in contracts with NHS England Trusts to: o Further integrate Zesty with Oracle Cerner and widely-used diagnostic booking systems (Cris and Soliton); o Enhance Form Builder module to support waitlist validation; and o Build new functionality, such as digitising maternity records. All platform and product enhancements underpin valuable upsell opportunities for FY25. · Launched Zesty in 4 new Trusts, including a new contract award in Q4 with George Elliot Hospital NHS Trust. Three additional Trusts are contracted to launch Zesty within the next 12 months. · Successfully built and launched the first phase of our integrated product which enables a patient to view and launch their Attend Anywhere consultation from within Zesty. Five customers have already purchased the integrated functionality. · NHS Wales agreed to a 9-month extension for £730,858 in order to prepare for a new procurement, which was expected under NHS procurement rules given the length of a new contract. Induction expects to release its audited results for the year ending 31 March 2024 on 1 July 2024. |
Posted at 23/4/2024 12:45 by citys2874 NHS England Renewal and hospitals tend to buy in April make this very cheap and should double up in price between now and end of May |
Posted at 17/4/2024 16:52 by citys2874 Remote consultation services in secondary care. Should see Induction Attend Anywhere ("AA") contracts have been successfully extended or renewed across NHS England ...expect 2-3 year contracts RNS very soon....this RNS should see share price bounce up past 20.00s |
Posted at 17/4/2024 13:59 by citys2874 very cheap at this price ....could see this bounce back to mid 20.00s very soon...multi-bagger at this price |
Posted at 09/1/2023 11:08 by hybrasil Just don't understand the maths here.This was floated at 115p a share in 2019. The mcap at flotation was 35m. The shares have since fallen to 22p but the mcap is still 20m.. How come? |
Posted at 21/5/2021 10:02 by dekle The drop yesterday made the placing price seem less of a discount |
Posted at 25/3/2021 11:13 by 74tom Strongly suspect that a placing is on the way here;Cash at 30th September = £5.01m Operating cash burn in 6 months to 30th September = £2.4m Probable cash balance at 25/03 = £2.5m or so Enough to last another 6 months. 5 x RNS releases in the last 14 trading days is always a sure sign they are trying to increase the share price and thus reduce dilution. Admirable, but whether it's good for PI's depends on the discount. Interesting to see what happens & whether they provide any clarity on revenues, as recent RNS's are missing any financial figures / are pure fluff. |
Posted at 15/3/2021 22:56 by megasonic Built up a healthy holding in INHC these past few weeks. RNSs on a number of contract wins in the last few days and the resulting share price action suggest this was a wise investment.INHC looks a real solid MedTech business, seems to have plenty of buy in from medical professionals.Expect |
Posted at 09/7/2020 12:51 by sphere25 Scubadiverr,In this instance, it's the well publicised Woodford debacle and Link Fund Solutions (holding 10.34% of the company's stock as per the RNS dated 09/06/2020) acting as administrator to place the funds. It has been a similar theme recently at the likes of PURP, TRX and DDDD. Identifying an overhang in general would be an interesting question. Beyond news highlighting distressed or forced fund sellers, you can look for persistent sellers via holding RNS and where stocks appear to be artificially suppressed from reaching a higher valuation. An example of this would be TSL where Simon Thompson has recently written an article on Investors Chronicle highlighting the increasing disparity between the valuation of the stock relative to the ever increasing value of the stake it has in AfterPay. TSL has substantially lagged the move higher in the company it owns a stake in and the holding RNS show that this appears to be because of Lombard using the opportunity of higher market demand to sell down a very significant stake. They have sold down their stake from 18.7% of the company in mid May to 4.51% as at the 30th June. There have been numerous overhang plays in the past, but note that there is no guarantee that the stock will rally strong too - it does depend on the fundamentals of the stock too, short term rises can be sold into or stale moves can occur. INHC is such an example as it's highly speculative and could find other sellers in the market wanting to sell at the overhang clearance levels, so it ultimately depends on the fundamentals. Clearly if this stock starts show more on the fundamental front, it changes the picture entirely. Hope this helps All imo DYOR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
.png){kind=logo}
